These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27243238)

  • 1. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of concurrent involved-field radiotherapy and intrathecal chemotherapy for leptomeningeal metastasis from solid tumors.
    Pan Z; Chen K; He H; Jiang T; Song Y; Pang X; Ye X; Wang M; Zhou T; Dong L; Yang G
    Radiother Oncol; 2023 Sep; 186():109740. PubMed ID: 37315582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
    Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
    J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
    Rudnicka H; Niwińska A; Murawska M
    J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study.
    Zhou T; Zhu S; Xiong Q; Gan J; Wei J; Cai J; Liu A
    BMC Cancer; 2023 Apr; 23(1):333. PubMed ID: 37041504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.
    Du C; Hong R; Shi Y; Yu X; Wang J
    J Neurooncol; 2013 Nov; 115(2):285-91. PubMed ID: 24000114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of leptomeningeal metastasis in solid tumors.
    Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
    Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
    Fan C; Jiang Z; Teng C; Song X; Li L; Shen W; Jiang Q; Huang D; Lv Y; Du L; Wang G; Hu Y; Man S; Zhang Z; Gao N; Wang F; Shi T; Xin T
    ESMO Open; 2024 Apr; 9(4):102384. PubMed ID: 38377785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal metastasis in solid tumors with a special focus on lung cancer.
    Joshi A; Ghosh J; Noronha V; Parikh PM; Prabhash K
    Indian J Cancer; 2014; 51(4):410-3. PubMed ID: 26842139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials on intrathecal pemetrexed treated leptomeningeal metastases from solid tumors].
    Pan ZY; Song YY; Jiang TC; Yang X; Yang GZ
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):112-119. PubMed ID: 35073657
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
    Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
    Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
    Chen TW; Jan IS; Chang DY; Lin CH; Chen IC; Chen HM; Cheng AL; Lu YS
    J Neurooncol; 2020 May; 148(1):165-172. PubMed ID: 32346837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.